Sofinnova Investments’s Dermira, Inc. DERM Stock Holding History

Sofinnova Investments’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-545,466	Closed	-$8.27M	–	78
2019 Q4	$8.27M	Sell	545,466 -444,702	-45%	-$3.84M	0.6%	33
2019 Q3	$6.33M	Buy	990,168 +330,286	+50%	+$2.76M	0.57%	37
2019 Q2	$6.31M	Buy	659,882 +176,242	+36%	+$1.9M	0.58%	36
2019 Q1	$6.55M	Sell	483,640 -58,584	-11%	-$489K	0.63%	29
2018 Q4	$3.9M	Buy	542,224 +46,931	+9%	+$513K	0.49%	39
2018 Q3	$5.4M	Buy	495,293 +130,953	+36%	+$1.32M	0.48%	35
2018 Q2	$3.35M	Buy	364,340 +316,020	+654%	+$2.95M	0.38%	44
2018 Q1	$386K	Buy	+48,320	New	+$1.05M	0.07%	34

Sofinnova Investments's DERM Position: Q1 2020 in Review

Sofinnova Investments sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 545,466 shares — an estimated $8.27M sold.

Sofinnova Investments first reported a position in DERM in Q1 2018 and held it in 8 quarters. The position peaked at $8.27M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Sofinnova Investments reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Sofinnova Investments sold 545,466 Dermira, Inc. shares in Q1 2020, an estimated $8.27M.
Sofinnova Investments first reported a position in Dermira, Inc. in Q1 2018 and held it in 8 quarters.
Sofinnova Investments's Dermira, Inc. position peaked at $8.27M in Q4 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Sofinnova Investments's 13F filing for Q1 2020, filed 13 May 2020.